Health Diaries > The Prostate Cancer Blog
February 2, 2007
Brachytherapy and Long-Term Prostate Cancer Survival
A study published in the February 1 issue of the International Journal for Radiation Oncology Biology Physics shows that brachytherapy, often referred to as seed implants, can result in high long-term survival rates among men with prostate cancer.
Among more than 2,600 men who received permanent brachytherapy implants for stage T1 or T2 disease, 93% of those who received doses of at least 130 Gray to more than 90% of the prostate had an eight-year PSA-relapse-free survival, reported Michael J. Zelefsky, M.D., of Memorial Sloan-Kettering Cancer Center, and colleagues.
Brachytherapy Sows Seeds of Prostate Cancer Survival
Tags: prostate cancer, cancer news, brachytherapy, seed implants
